Headshot squre
Platelet BioGenesis
Cambridge Massachusetts        UNITED STATES
Sven is the Co-Founder and President of Platelet BioGenesis: a VC-backed, development-stage Harvard spinout making platelets from clinical grade induced pluripotent stem cells. Platelets are the cells in your blood that stop you from bleeding and also play critical roles in cancer and other diseases. The company is leveraging their platelet (PLT+) platform for developing designer platelets for therapeutic purposes, unlocking a new class of therapeutics that takes advantage of the unique natural properties of platelets. Prior to founding Platelet BioGenesis, Sven worked in M&A and Business Development at J.P. Morgan, as an analyst at a hedge fund, and as a venture capital investor where he also served on numerous Boards. Sven received his B.S. in Engineering from Cornell University and an MBA with Distinction from New York University’s Stern School of Business